Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
Healthy Volunteers
ID06815250

Effectiveness of the Influenza and Tdap Vaccination Educational Module in Improving Knowledge and Future Vaccination Uptake Among Pregnant Mothers in Primary Care Clinics

Led by Universiti Putra Malaysia · Updated on 2026-05-01

351

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate whether a web-based educational program, called the InTroDuce-Programme, can improve pregnant women's knowledge about Influenza and Tdap vaccinations and increase their intention to get vaccinated in the future. The study focuses on understanding how demographic factors, attitudes, and barriers affect vaccination decisions among pregnant mothers. It is a randomized controlled trial conducted in primary care clinics to compare the educational program with standard antenatal care. Participants in the study will either receive the InTroDuce-Programme, which is a comprehensive web-based module covering the importance, safety, and effectiveness of influenza and Tdap vaccines along with addressing common concerns, or they will receive standard antenatal care without the additional educational module. The clinics are randomly assigned to either the intervention or control group to reduce contamination. The study lasts 12 months with recruitment over 6 months and includes a follow-up one month after the intervention. During the study, participants will complete questionnaires before and after the intervention to assess changes in vaccination knowledge and future vaccination intentions. The main outcomes measured are knowledge improvement and vaccination uptake intentions one month post-intervention, along with barriers to vaccination. The study involves data collection through validated questionnaires and statistical analysis to understand the effectiveness of the educational program.

CONDITIONS

Brief Title

Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant women aged 18 years and older
  • At or before 32 weeks of gestation
  • Able to understand and consent to participation in the study
Not Eligible

You will not qualify if you...

  • Pregnant women with severe allergic reactions to previous doses of influenza or Tdap vaccines
  • Non-Malaysian citizens

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - Up to 6 months during pregnancy

Participants assigned to the intervention group complete the Influenza and Tdap Vaccination Web-based Educational and Learning Module (InTroDuce-Programme) to improve knowledge and future vaccination uptake. Participants in the control group receive standard antenatal care without the educational module.

Initial visit to receive the educational module or standard care, followed by 1 follow-up visit 1 month later

Trial Site Locations

Total: 4 locations

1

Klinik Kesihatan Bangi

Bandar Baru Bangi, Selangor, Malaysia, 43650

Actively Recruiting

2

Klinik Kesihatan Batu 9

Cheras, Selangor, Malaysia, 43200

Actively Recruiting

3

Klinik Kesihatan Balakong

Cheras, Selangor, Malaysia, 43300

Actively Recruiting

4

Klinik Kesihatan Kajang

Kajang, Selangor, Malaysia, 43000

Actively Recruiting

Loading map...

Research Team

H

Hung Chiun Lau, Dr Fam Med

S

Siew Mooi Ching, Fam Med

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Incidence of influenza during pregnancy and association with pregnancy and perinatal outcomes in three middle-income countries: a multisite prospective longitudinal cohort study.

Fatimah S Dawood, Wanitchaya Kittikraisak, Archana Patel...

https://pubmed.ncbi.nlm.nih.gov/33129424

Assessment of knowledge and attitude towards influenza and pertussis vaccination in pregnancy and factors affecting vaccine uptake rates: a cross-sectional survey.

Eliane Yuting Hong, Kanaka Kulkarni, Arundhati Gosavi...

https://pubmed.ncbi.nlm.nih.gov/34544209

Interventions to increase vaccination against COVID-19, influenza and pertussis during pregnancy: a systematic review and meta-analysis.

Mohammad S Razai, Rania Mansour, Lucy Goldsmith...

https://pubmed.ncbi.nlm.nih.gov/37934788

Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months.

Lore Merdrignac, Lesly Acosta, Adele Habington...

https://pubmed.ncbi.nlm.nih.gov/36182617